相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA
K. Saune et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Plasma HIV-1 RNA Levels During Antiretroviral Therapy: How Low Is Low Enough?
Rajesh T. Gandhi et al.
CLINICAL INFECTIOUS DISEASES (2012)
Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy
Tomas Doyle et al.
CLINICAL INFECTIOUS DISEASES (2012)
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml
Stephanie Haim-Boukobza et al.
AIDS (2011)
Dramatic Decline in the HIV-1 RNA Level Over Calendar Time in a Large Urban HIV Practice
Richard D. Moore et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR Assays
Jean-Marie Sire et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection
Vikram S. Gill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level
Viviane D. Lima et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A large French prospective cohort of HIV-infected patients: the Nadis Cohort
P. Pugliese et al.
HIV MEDICINE (2009)
Ultrasensitive Assessment of Residual HIV Viraemia in HAART-Treated Patients With Persistently Undetectable Plasma HIV-RNA: A Cross-Sectional Evaluation
Stefano Bonora et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
Michael Rosenblum et al.
PLOS ONE (2009)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection
Curtis L. Cooper et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2007)
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures
Andrew A. Benzie et al.
AIDS (2007)
Impact of chronic hepatitis C on HIV-1 disease progression
JC Martín et al.
HIV CLINICAL TRIALS (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)